iRhythm Holdings (IRTC) Dropped Despite Posting Beat-And-Raise Results

2 hours ago 2

Soumya Eswaran

Thu, June 25, 2026 astatine 9:33 AM CDT 3 min read

Carillon Tower Advisers, an concern absorption company, released its first-quarter 2026 capitalist missive for the "Carillon Eagle Small Cap Growth Fund". A transcript of the missive tin beryllium downloaded here. Small-cap stocks delivered mixed results successful the 4th arsenic the marketplace favored worth stocks implicit growth. The Russell 2000 Growth Index fell 2.82% successful the quarter, portion the Russell 2000® Value Index accrued 4.96%.  The archetypal 4th saw equity marketplace volatility owed to Iran strikes, boosting vigor prices. The steadfast is optimistic that the turbulence successful the marketplace volition beryllium short-lived, with improved valuations and imaginable affirmative developments from de-escalation successful the Middle East. In addition, delight cheque the Fund's apical 5 holdings to cognize its champion picks successful 2026.

In its first-quarter 2026 capitalist letter, Carillon Eagle Small Cap Growth Fund highlighted IRhythm Holdings, Inc. (NASDAQ:IRTC). IRhythm Holdings, Inc. (NASDAQ:IRTC) is simply a integer healthcare institution that provides Zio ambulatory cardiac monitoring services. The company, antecedently known arsenic iRhythm Technologies, Inc., changed its sanction to iRhythm Holdings, Inc. successful January 2026. On June 24, 2026, IRhythm Holdings, Inc. (NASDAQ:IRTC) closed astatine $112.47 per share. One-month instrumentality of IRhythm Holdings, Inc. (NASDAQ:IRTC) was -2.72%, and its shares mislaid 26.34% implicit the past 52 weeks. IRhythm Holdings, Inc. (NASDAQ:IRTC) has a marketplace capitalization of $3.7 billion.

Carillon Eagle Small Cap Growth Fund stated the pursuing regarding IRhythm Holdings, Inc. (NASDAQ:IRTC) successful its Q1 2026 capitalist letter:

"IRhythm Holdings, Inc. (NASDAQ:IRTC) is simply a integer healthcare institution that develops wearable, AI-driven cardiac monitoring devices. The banal struggled contempt delivering beat-and-raise results. Broader weakness successful the healthcare instrumentality and supplies industry, arsenic investors rotated into cyclical and exertion stocks, weighed connected performance. Additional unit came from a US Department of Justice Civil Investigative Demand (DOJ CID) received successful December related to mobile cardiac telemetry services rendered successful 2023 via iRhythm's Zio AT signaling device. This enquiry is constricted successful scope arsenic it lone accounts for a tiny information of full income and the hazard has already been priced in. We don't work excessively overmuch into the com pany's caller alteration of auditors."

IRhythm Holdings, Inc. (NASDAQ:IRTC) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 37 hedge money portfolios held IRhythm Holdings, Inc. (NASDAQ:IRTC) astatine the extremity of the archetypal quarter, compared to 44 successful the erstwhile quarter. While we admit the imaginable of IRhythm Holdings, Inc. (NASDAQ:IRTC) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article